Increased levels of soluble interleukin-2 receptors (IL-2R) in serum were observed in both Plasmodium falciparum-and P. vivax-infected individuals compared with nonparasitemic subjects. Clinical symptoms of P. falciparum malaria were associated with higher levels of soluble IL-2R. Temporal evolution in serum of IL-2R during the course of a malaria attack mimicked the kinetics of soluble IL-2R under experimental conditions. Interleukin-2 is generally considered to play a pivotal role in the cellular immune response by regulating the proliferation of antigen-activated T lymphocytes expressing specific interleukin-2 receptors (IL-2R) on their surfaces (10). During the immune response, a soluble form of IL-2R is released by activated cells and can be detected in culture supernatants and serum (9). The precise immunoregulatory role of soluble IL-2R is unknown, but its increase has been demonstrated in various Iymphoreticular diseases in which a strong immune reaction occurs (2, 4, 8) . Levels of soluble IL-2R are also elevated in selected parasitic infections, including malaria (5. 7). We report here additional evidence of increased levels of IL-2R in Plasmodiurn falciparuitn and P. l'i'(Ix malaria, as well as the results of a longitudinal study of the release in serum of these soluble receptors of IL-2.
Interleukin-2 is generally considered to play a pivotal role in the cellular immune response by regulating the proliferation of antigen-activated T lymphocytes expressing specific interleukin-2 receptors (IL-2R) on their surfaces (10) . During the immune response, a soluble form of IL-2R is released by activated cells and can be detected in culture supernatants and serum (9) . The precise immunoregulatory role of soluble IL-2R is unknown, but its increase has been demonstrated in various Iymphoreticular diseases in which a strong immune reaction occurs (2, 4, 8) . Levels of soluble IL-2R are also elevated in selected parasitic infections, including malaria (5. 7). We report here additional evidence of increased levels of IL-2R in Plasmodiurn falciparuitn and P. l'i'(Ix malaria, as well as the results of a longitudinal study of the release in serum of these soluble receptors of IL-2.
Serum samples were collected in Madagascar during a cohort study (6) . First, IL-2R was measured in samples collected from 95 individuals presenting with P. fùlcipurum or P. viv'zax blood parasites and from nonparasitemic individuals. No individual had presented with malaria parasites on the four previous weekly thick blood smears. Thirty-nine P. flclkiparuin-infected individuals (parasite density, 16 to 320,000/4l; geometric mean parasite density, 2,993/~tl) were studied. Nine had a symptomatic P. fiil(kiparulin malaria, and thirty had an asymptomatic infection. Eighteen P. v'ivaxinfected individuals (parasite density, 244 to 5.667/pil; geometric mean parasite density, 1,018/1jl) were studied. Eight had a symptomatic infection, and ten had an asymptomatic infection. In both P. fJakciparumn-and P. i'ivax-infected individuals, parasite densities were similar in symptomatically and asymptomatically infected individuals. Thirty-eight healthy, nonparasitemic individuals were studied. All individuals were 10 to 62 years old; the mean ages of P. falciparian-and P. i'ii'a.v-infected individuals and of those who were non-parasitemic were similar (29.2 + 12.9 years). Sex ratios were also similar (male/female ratio, 0.63) in al three groups of individuals.
In addition, IL-2R was measured in serum samples collected every 2 weeks for 4 weeks from 28 subjects. At the first (W-2) and last (W+2) serum collections, all individuals presented with a negative blood smear. At the second collection of serum (WO), 12 individuals were infected with P. Jalciparuin (4 had clinical symptoms), 10 were infected * Corresponding author.
with P. *iva.a (4 had clinical symptoms), and 6 were nonparasitemic.
The In the transversal study, the three groups of subjects exhibited different levels of serum IL-2R (P < 0.0001) (Fig.  1) . The IL-2R levels were similar in individuals infected with P. jfidiparunm (range, 480 to 4,200 U/ml; mean, 1,409 + 681 U/ml) and P. vii'ax (range, 420 to 2,600 U/ml; mean, 1,384 579 U/ml) and were lower in nonparasitemic individuals (range. 220 to 1,110 U/ml; mean, 662 217 U/ml) (for both, P < 0.0005). Among P. Jùlc-iparlumti-infected subjects, higher levels of IL-2R were observed in those with clinical symptoms of malaria (range, 700 to 4,200 U/ml; mean, 1,804 + 1,147 U/ml) than in those with no symptoms (range, 480 to 2,170 U/ml; mean, 1, 291 427 U/ml) (P < 0.5). This difference was not observed among P. ii'iax-infected individuals. No correlation was observed between IL-2R levels and parasite counts or age of the subjects.
The W-2 serum IL-2R levels of the 28 subjects who were monitored longitudinally (range, 390 to 1,110 U/ml; mean, 685 216 U/ml) were similar to the levels of the 38 noninfected individuals previously studied. No temporal variation of soluble IL-2R was observed in the six individuals who remained nonparasitemic (Fig. 2) . Ten of the twelve subjects who developed a P. jàlciparuni infection exhibited a rise in their IL-2R serum level at WO, and nine of those ten exhibited a subsequent decline at W+2. Similar evolution occurred in 9 of the 10 individuals infected with P. i'i'ax. The three remaining subjects had similar levels of IL-2R at W-2 and WO. but this level rose in two of them (one infected with P. fa1l(cipari-i/n and one with P. *'ia.S) at W+2. the number of investigated subjects was small. and none were suffering from a severe malar-ia attack. Whether the malaria-associated symptomatology originates fi-om or is a consequence of the immune response remains to be determined. Our longitudinal study gives further evidence of the role of malaria in the release of IL-2R in serum of infected subjects. The temporal evolution of IL-2R levels in the sera of' malaria-infected subjects mimics the kinetics of IL-2R observed under experimental conditions. as reported by Cantrell and Smith (1) . Following activation of peripheral mononuclear celîs by phytohemagglutinin, IL-2R was detected at its maximum level within 3 to 4 d-ays and declined to a very low level after 2 weeks of culture. All but one subject with increased IL-2R during infection exhibited IL-2R levels within the normal range 2 weeks later. Conversely, two infected subjects had similar levels of IL-2R alt WO and W-2 but raised levels at W+2. In these two subjects. parasites might have proliferated in blood for too short a time prior to the WO blood collection to allow expression and release of IL-2R in serum. Such a phenomenon might also have happened in some individuals in the transversal study. The last subject who showed no variation in serum IL-2R may have had either an unknown rise and decline of IL-2R (between WO and W+2) or a lack of the immune response originating expression or release of IL-2R.
Increase in soluble IL-2R in P. tùl(ipwun and P. iiu.vmalaria probably reflects antigen-specific lymphocyte activation and clonal expansion. The level of IL-2R may be used to study the responses of the involved cellular subpopulations (which remain to be determined). High circulating levels of IL-2R might be able to bind interleukin-2 and be responsible for the immunosuppression observed during the acute phase of malaria. Whether this increase has beneficial or negative (as tumor necrosis factor [3] ) effects also remains to be clarified.
